πŸ‡ΊπŸ‡Έ FDA
Patent

US 8314088

Pyrazinooxazepine derivatives

granted A61KA61K9/2018A61K9/2059

Quick answer

US patent 8314088 (Pyrazinooxazepine derivatives) held by Takeda Pharmaceutical Company Limited expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K9/2018, A61K9/2059, A61K9/286, A61P